• 6767 Bertner Ave, Mitchell Basic Science Research Building

    77030 Houston

    United States

  • 4748 Citations
  • 39 h-Index
19962019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 17 Similar Profiles
gemcitabine Medicine & Life Sciences
Pancreatic Neoplasms Medicine & Life Sciences
Cholangiocarcinoma Medicine & Life Sciences
Survival Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences
Gallbladder Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

7 Citations (Scopus)

Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer

Bernard, V., Kim, D. U., San Lucas, F. A., Castillo Arias, J. A., Allenson, K., Mulu, F. C., Stephens, B. M., Huang, J., Semaan, A., Guerrero, P. A., Kamyabi, N., Zhao, J., Hurd, M. W., Koay, E. J., Taniguchi, C., Herman, J. M., Javle, M., Wolff, R. A., Katz, M. H., Varadhachary, G. R. & 2 othersMaitra, A. & Alvarez, H. A., Jan 1 2019, In : Gastroenterology. 156, 1, p. 108-118.e4

Research output: Contribution to journalArticle

Pancreatic Neoplasms
Nucleic Acids
Exosomes
Circulating Neoplastic Cells
DNA
gemcitabine
Adenocarcinoma
Drug Therapy
130-nm albumin-bound paclitaxel
Confidence Intervals

Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers: A Phase 2 Clinical Trial

Shroff, R., Javle, M., Xiao, L., Kaseb, A., Varadhachary, G. R., Wolff, R. A., Raghav, K. P. S., Iwasaki, M., Masci, P., Ramanathan, R. K., Ahn, D. H., Bekaii-Saab, T. S. & Borad, M. J., Jan 1 2019, In : JAMA Oncology.

Research output: Contribution to journalArticle

gemcitabine
Biliary Tract Neoplasms
Nanoparticles
Cisplatin
Clinical Trials

Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignancies

Bhatty, M., Kato, S., Piha-Paul, S. A., Naing, A., Subbiah, V., Huang, H. J., Karp, D. D., Tsimberidou, A. M., Zinner, R. G., Hwu, W-J., Javle, M., Patel, S. P., Hu, M. I-N., Varadhachary, G. R., Conley, A. P., Ramzanali, N. M., Holley, V. R., Kurzrock, R., Meric-Bernstam, F., Kwang Chae, Y. & 3 othersKim, K. B., Falchook, G. S. & Janku, F., Feb 1 2019, In : Cancer. 125, 3, p. 463-472 10 p.

Research output: Contribution to journalArticle

Carboplatin
Paclitaxel
Melanoma
Mitogen-Activated Protein Kinase Kinases
Neoplasms

Preoperative drainage for perihilar cholangiocarcinoma

Odisio, B. C., Krampitz, G. W., Murthy, R., Mahvash, A., Javle, M. & Vauthey, J. N., Jan 1 2019, In : The Lancet Gastroenterology and Hepatology. 4, 1, p. 10-11 2 p.

Research output: Contribution to journalLetter

Klatskin Tumor
Drainage